Published in J Clin Psychiatry on November 01, 1999
The impact of experiential avoidance on the reduction of depression in treatment for borderline personality disorder. Behav Res Ther (2009) 1.12
Characterizing emotional dysfunction in borderline personality, major depression, and their co-occurrence. Compr Psychiatry (2015) 0.81
Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities. Neuropsychiatr Dis Treat (2015) 0.78
The relationship between borderline personality disorder and bipolar disorder. Dialogues Clin Neurosci (2013) 0.78
Severity of anxiety symptoms reported by borderline patients and Axis II comparison subjects: description and prediction over 16 years of prospective follow-up. J Pers Disord (2014) 0.77
Borderline personality disorder: current drug treatments and future prospects. Ther Adv Chronic Dis (2010) 0.76
Personality disorders and the persistence of anxiety disorders: evidence of a time-of-measurement effect in NESARC. J Anxiety Disord (2013) 0.76
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med (2000) 10.25
Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA (2001) 5.37
Irritable bowel syndrome and psychiatric illness. Am J Psychiatry (1990) 2.18
A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care. Arch Gen Psychiatry (2001) 2.08
Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry (1990) 1.87
Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry (1990) 1.84
Drug preferences of alcoholic polydrug abusers with and without panic. J Clin Psychiatry (1990) 1.39
Search for pathophysiology of panic disorder. Lancet (1998) 1.37
Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry (1988) 1.35
The Tridimensional Personality Questionnaire in depression: state versus trait issues. J Psychiatr Res (1996) 1.31
Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology (1998) 1.31
Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry (1993) 1.23
Chronicity of depressive episode in relation to antidepressant-placebo response. Neuropsychopharmacology (1991) 1.21
Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry (1994) 1.13
Panic disorder precipitated by exposure to organic solvents in the work place. Am J Psychiatry (1987) 1.12
Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry (1976) 1.11
Antidepressants in the medically ill: diagnosis and treatment in primary care. Clin Chem (1988) 1.08
Life events at the onset of bipolar affective illness. Am J Psychiatry (1979) 1.06
Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry (1974) 1.05
Predictors and outcome of discharge against medical advice from the psychiatric units of a general hospital. Psychiatr Serv (1998) 1.03
Rapid cycling manic depressive patients. Compr Psychiatry (1978) 1.03
Life events and primary affective illness. Acta Psychiatr Scand (1978) 1.03
Reduced catechol-O-methyltransferase activity in red blood cells of women with primary affective disorder. Science (1970) 1.01
Lithium response in unipolar versus bipolar depression. Am J Psychiatry (1972) 1.01
Rubidium: biochemical, behavioral, and metabolic studies in humans. Am J Psychiatry (1973) 1.00
Heritable factors in the severity of affective illness. Biol Psychiatry (1976) 1.00
Repetitive transcranial magnetic stimulation in the treatment of medication-resistant depression: preliminary data. J Nerv Ment Dis (1999) 0.99
Reduced benzodiazepine sensitivity in patients with panic disorder: comparison with patients with obsessive-compulsive disorder and normal subjects. Am J Psychiatry (1996) 0.97
Cardiac sinus node dysfunction during lithium treatment. Am J Psychiatry (1979) 0.97
Plasma DOPA response to levodopa administration in man: effects of a peripheral decarboxylase inhibitor. Clin Pharmacol Ther (1971) 0.95
The life table. A method for analyzing longitudinal studies. Arch Gen Psychiatry (1976) 0.95
Incidence of side effects in patients on long-term lithium therapy. Am J Psychiatry (1980) 0.94
Treatement of excessive weight gain in patients taking lithium. Am J Psychiatry (1976) 0.94
Hyperventilation and panic disorder. Am J Med (1987) 0.94
Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities? Neuropsychopharmacology (1998) 0.94
The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord (1996) 0.93
Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. Am J Psychiatry (1998) 0.92
Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psychiatry (1978) 0.91
Development of a brief diagnostic screen for panic disorder in primary care. Psychosom Med (1999) 0.91
Effects of one night's sleep deprivation on mood and behavior in panic disorder. Patients with panic disorder compared with depressed patients and normal controls. Arch Gen Psychiatry (1986) 0.91
The relationship of menstrually related mood disorders to psychiatric disorders. Clin Obstet Gynecol (1987) 0.91
Lithium carbonate in affective disorders. IV. A double-blind study of prophylaxis in unipolar recurrent depression. Arch Gen Psychiatry (1975) 0.91
Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol (1995) 0.91
Relationship of childhood physical and sexual abuse to adult bipolar disorder. Bipolar Disord (2000) 0.91
Differential subtyping of depression. Depress Anxiety (2001) 0.90
Effortful and automatic cognitive processes in depression. Arch Gen Psychiatry (1986) 0.90
Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry (1976) 0.90
Relationship between a GABAA alpha 6 Pro385Ser substitution and benzodiazepine sensitivity. Am J Psychiatry (1999) 0.90
Mixed anxiety and depression. J Abnorm Psychol (1991) 0.90
Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety (1997) 0.89
Determinants of suicidal ideation: the role of substance use disorders. J Clin Psychiatry (1997) 0.89
Lithium erythrocyte: plasma ratio in primary affective disorder. Compr Psychiatry (1978) 0.89
Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. Am J Psychiatry (1973) 0.89
Lithium carbonate prophylaxis failure. Br J Psychiatry (1976) 0.88
Life events and the onset of panic disorder. Am J Psychiatry (1986) 0.88
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial. J Clin Psychiatry (2001) 0.88
Dawn simulation and bright light in the treatment of SAD: a controlled study. Biol Psychiatry (2001) 0.88
Carbamazepine and thyroid function in affectively ill patients. Clinical and theoretical implications. Arch Gen Psychiatry (1984) 0.87
Toward the validation of RDC schizoaffective disorder. Arch Gen Psychiatry (1980) 0.87
DSM-III-R personality disorders in a mood and anxiety disorders clinic: prevalence, comorbidity, and clinical correlates. J Affect Disord (1993) 0.87
Statistical predictions of suicide in depressives. Compr Psychiatry (1980) 0.87
Morning or evening bright light treatment of winter depression? The significance of hypersomnia. Biol Psychiatry (1991) 0.86
Antidepressant effects of carbamazepine. Am J Psychiatry (1986) 0.86
Effect of diazepam on plasma gamma-aminobutyric acid in sons of alcoholic fathers. Alcohol Clin Exp Res (1996) 0.86
The course of development of mania in patients with recurrent depression. Am J Psychiatry (1976) 0.86
Dysphoric mania. Clinical and biological correlates. Arch Gen Psychiatry (1989) 0.86
Relationships between neuropsychological and oculomotor measures in schizophrenia patients and normal controls. Biol Psychiatry (1997) 0.85
Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients. Am J Psychiatry (1982) 0.85
Clinical and differential diagnostic aspects of treatment-resistant depression. J Psychiatr Res (1995) 0.85
Long-term course and outcome in panic disorder: a naturalistic follow-up study. Anxiety (1996) 0.85
Onset of response in relation to outcome in depressed outpatients with placebo and imipramine. J Affect Disord (1989) 0.85
Psychopathology in systemic lupus erythematosus. II. Relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4. Semin Arthritis Rheum (1973) 0.84
The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry (1986) 0.84
Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial. J Clin Psychopharmacol (2000) 0.84
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Ann Clin Psychiatry (1998) 0.84
Effects of diphenhydramine on human eye movements. Psychopharmacology (Berl) (1995) 0.84
Lactate vulnerability after alprazolam versus placebo treatment of panic disorder. Biol Psychiatry (1991) 0.83
Determinants of pharmacologic treatment failure in panic disorder. J Clin Psychiatry (1997) 0.83
Social outcome compared in psychotic and nonpsychotic bipolar I patients. J Nerv Ment Dis (1983) 0.83
Correlates of antimanic response to carbamazepine. Psychiatry Res (1987) 0.83
Lithium treatment in older patients. Am J Psychiatry (1979) 0.83
Human oculomotor function: reliability and diurnal variation. Biol Psychiatry (1995) 0.83
Benzodiazepine pharmacodynamics: utility of eye movement measures. Psychopharmacology (Berl) (1993) 0.83
Premenstrual changes: a comparison of five populations. Psychiatry Res (1986) 0.82
Longitudinal course of panic disorder: clinical and biological considerations. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.82
A case of psychosis and delirium following withdrawal from triazolam. J Clin Psychiatry (1987) 0.82
Panic disorder in the medically ill. J Clin Psychiatry (1989) 0.82
Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. J Clin Psychiatry (1986) 0.82
Mirtazapine for depression in patients with human immunodeficiency virus. J Clin Psychopharmacol (2000) 0.82